Beate Wild1, Anne Eckl2, Wolfgang Herzog2, Dorothea Niehoff2, Sabine Lechner2, Imad Maatouk2, Dieter Schellberg2, Hermann Brenner3, Heiko Müller3, Bernd Löwe4. 1. Departments of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany. Electronic address: beate.wild@med.uni-heidelberg.de. 2. Departments of General Internal Medicine and Psychosomatics, Medical University Hospital, Heidelberg, Germany. 3. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. 4. Department of Psychosomatics and Psychotherapy, Medical University Hospital, Hamburg, Germany.
Abstract
OBJECTIVE: The aim of this study was to evaluate the validity of the seven-item Generalized Anxiety Disorder scale (GAD-7) and its two core items (GAD-2) for detecting GAD in elderly people. METHODS: A criterion-standard study was performed between May and December of 2010 on a general elderly population living at home. A subsample of 438 elderly persons (ages 58-82) of the large population-based German ESTHER study was included in the study. The GAD-7 was administered to participants as part of a home visit. A telephone-administered structured clinical interview was subsequently conducted by a blinded interviewer. The structured clinical (SCID) interview diagnosis of GAD constituted the criterion standard to determine sensitivity and specificity of the GAD-7 and the GAD-2 scales. RESULTS: Twenty-seven participants met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for current GAD according to the SCID interview (6.2%; 95% confidence interval [CI]: 3.9%-8.2%). For the GAD-7, a cut point of five or greater appeared to be optimal for detecting GAD. At this cut point the sensitivity of the GAD-7 was 0.63 and the specificity was 0.9. Correspondingly, the optimal cut point for the GAD-2 was two or greater with a sensitivity of 0.67 and a specificity of 0.90. The areas under the curve were 0.88 (95% CI: 0.83-0.93) for the GAD-7 and 0.87 (95% CI: 0.80-0.94) for the GAD-2. The increased scores on both GAD scales were strongly associated with mental health related quality of life (p <0.0001). CONCLUSION: Our results establish the validity of both the GAD-7 and the GAD-2 in elderly persons. Results of this study show that the recommended cut points of the GAD-7 and the GAD-2 for detecting GAD should be lowered for the elderly general population.
OBJECTIVE: The aim of this study was to evaluate the validity of the seven-item Generalized Anxiety Disorder scale (GAD-7) and its two core items (GAD-2) for detecting GAD in elderly people. METHODS: A criterion-standard study was performed between May and December of 2010 on a general elderly population living at home. A subsample of 438 elderly persons (ages 58-82) of the large population-based German ESTHER study was included in the study. The GAD-7 was administered to participants as part of a home visit. A telephone-administered structured clinical interview was subsequently conducted by a blinded interviewer. The structured clinical (SCID) interview diagnosis of GAD constituted the criterion standard to determine sensitivity and specificity of the GAD-7 and the GAD-2 scales. RESULTS: Twenty-seven participants met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for current GAD according to the SCID interview (6.2%; 95% confidence interval [CI]: 3.9%-8.2%). For the GAD-7, a cut point of five or greater appeared to be optimal for detecting GAD. At this cut point the sensitivity of the GAD-7 was 0.63 and the specificity was 0.9. Correspondingly, the optimal cut point for the GAD-2 was two or greater with a sensitivity of 0.67 and a specificity of 0.90. The areas under the curve were 0.88 (95% CI: 0.83-0.93) for the GAD-7 and 0.87 (95% CI: 0.80-0.94) for the GAD-2. The increased scores on both GAD scales were strongly associated with mental health related quality of life (p <0.0001). CONCLUSION: Our results establish the validity of both the GAD-7 and the GAD-2 in elderly persons. Results of this study show that the recommended cut points of the GAD-7 and the GAD-2 for detecting GAD should be lowered for the elderly general population.
Authors: Shun-Chiao Chang; Jennifer Prescott; Immaculata De Vivo; Peter Kraft; Olivia I Okereke Journal: J Psychiatr Res Date: 2018-05-26 Impact factor: 4.791
Authors: Manish N Shah; Matthew M Hollander; Courtney Mc Jones; Thomas V Caprio; Yeates Conwell; Jeremy T Cushman; Eva H DuGoff; Amy J H Kind; Michael Lohmeier; Ranran Mi; Eric A Coleman Journal: J Am Geriatr Soc Date: 2018-08-10 Impact factor: 5.562
Authors: Antje Gumz; Angelika Weigel; Karl Wegscheider; Georg Romer; Bernd Löwe Journal: Prim Health Care Res Dev Date: 2017-08-22 Impact factor: 1.458
Authors: Anna M Baker; Janet T Holbrook; Abebaw M Yohannes; Michelle N Eakin; Elizabeth A Sugar; Robert J Henderson; Anne S Casper; David A Kaminsky; Alexis L Rea; Anne M Mathews; Loretta G Que; Joe W Ramsdell; Lynn B Gerald; Robert A Wise; Nicola A Hanania Journal: Ann Am Thorac Soc Date: 2018-08
Authors: Galit Levi Dunietz; Leslie M Swanson; Erica C Jansen; Ronald D Chervin; Louise M O'Brien; Lynda D Lisabeth; Tiffany J Braley Journal: Sleep Date: 2018-09-01 Impact factor: 5.849
Authors: Brittany Litster; Kirsten M Fiest; Scott B Patten; John D Fisk; John R Walker; Lesley A Graff; James M Bolton; Jitender Sareen; James J Marriott; Lindsay I Berrigan; Charles N Bernstein; Ryan Zarychanski; Alexander Singer; Carol A Hitchon; Christine A Peschken; Ruth Ann Marrie Journal: Int J MS Care Date: 2016 Nov-Dec
Authors: Alexandra M V Wennberg; Clinton E Hagen; Rebecca F Gottesman; Vadim Zipunnikov; Christopher N Kaufmann; Marilyn S Albert; George W Rebok; Judith D Kasper; Adam P Spira Journal: Arch Gerontol Geriatr Date: 2017-05-16 Impact factor: 3.250